Skip to content

Clinical trials

Terminated Carcinoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma Status: Terminated Clear all

87 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20043
20051
20064
20073
200810
20096
20107
20112
20122
20132
20146
20154
20161
20174
20182
20195
20207
20215
20225
20233
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated87

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Blueprint Medicines Corporation3
Novartis Pharmaceuticals3
Abbott2
Amgen2
Assistance Publique - Hôpitaux de Paris2
Astellas Pharma Inc2
Inovio Pharmaceuticals2
LEO Pharma2
National Cancer Institute (NCI)2
University of Florida2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma87
Neoplasms35
Carcinoma, Non-Small-Cell Lung16
Adenocarcinoma14
Neoplasm Metastasis13
Neoplasms by Site11
Carcinoma, Renal Cell10
Neoplasms by Histologic Type10
Ovarian Neoplasms10
Colorectal Neoplasms8

Trials

Showing 26 to 50 of 87. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.